ZNF705CP: A Potential Drug Target and Biomarker (G389631)

ZNF705CP: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF705CP is a ZNF protein that is expressed in various tissues and is known for its unique structure and function. This protein has been identified as a potential drug target and biomarker. In this article, we will explore the ZNF705CP protein, its function, and its potential as a drug target.

Structure and Function

ZNF705CP is a 21 kDa protein that is expressed in various tissues, including brain, heart, and muscle. It has a unique structure that consists of a catalytic domain, a transmembrane region, and an intracellular domain. The catalytic domain is responsible for protein-protein interactions and catalytic activity, while the transmembrane region is responsible for the protein's ability to interact with the intracellular environment. The intracellular domain is responsible for the protein's ability to interact with intracellular signaling pathways.

ZNF705CP is involved in various cellular processes, including cell signaling, DNA replication, and apoptosis. It has been shown to play a role in various signaling pathways, including the TGF-β pathway, which is involved in cell signaling and growth. ZNF705CP has also been shown to be involved in DNA replication, which is critical for cell growth and division.

In addition to its role in cellular signaling, ZNF705CP has also been shown to have potential as a drug target. Its unique structure and function make it an attractive target for small molecules. Small molecules can be used to modulate the activity of ZNF705CP and inhibit its signaling pathways. This can lead to the inhibition of cellular processes that are abnormal in diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases.

Potential Applications

ZNF705CP has the potential to be a drug target for a variety of diseases. Its involvement in cellular signaling and its unique structure make it an attractive target for small molecules. Small molecules can be used to inhibit the signaling pathways of ZNF705CP and lead to the inhibition of cellular processes that are abnormal in diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases.

In addition to its potential as a drug target, ZNF705CP has the potential to be used as a biomarker. Its unique structure and function make it an attractive target for biomarker development. By using techniques such as mass spectrometry and affinity purification, it may be possible to identify small molecules that interact with ZNF705CP and can be used as biomarkers for diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases.

Conclusion

ZNF705CP is a unique protein that is involved in various cellular processes and has the potential to be a drug target and biomarker. Its unique structure and function make it an attractive target for small molecules. Small molecules can be used to inhibit the signaling pathways of ZNF705CP and lead to the inhibition of cellular processes that are abnormal in diseases such as cancer, neurodegenerative diseases, and cardiovascular diseases. In addition to its potential as a drug target and biomarker, ZNF705CP may also be used as a target for small molecules that are involved in cellular signaling and DNA replication.

Protein Name: Zinc Finger Protein 705C, Pseudogene

The "ZNF705CP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF705CP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A | ZNF75CP | ZNF75D | ZNF76 | ZNF761 | ZNF763 | ZNF764 | ZNF765 | ZNF766 | ZNF767P | ZNF768 | ZNF77 | ZNF770 | ZNF771 | ZNF772 | ZNF773 | ZNF774 | ZNF775 | ZNF776 | ZNF777 | ZNF778 | ZNF780A | ZNF780B | ZNF781 | ZNF782 | ZNF783 | ZNF784 | ZNF785 | ZNF786 | ZNF787 | ZNF788P | ZNF789 | ZNF79 | ZNF790 | ZNF790-AS1 | ZNF791 | ZNF792 | ZNF793 | ZNF799 | ZNF8 | ZNF8-ERVK3-1 | ZNF80 | ZNF800 | ZNF804A | ZNF804B | ZNF805 | ZNF807P | ZNF808 | ZNF81 | ZNF812P | ZNF813 | ZNF814 | ZNF815P | ZNF816 | ZNF816-ZNF321P | ZNF818P | ZNF821 | ZNF823 | ZNF826P | ZNF827 | ZNF829 | ZNF83 | ZNF830 | ZNF831 | ZNF833P | ZNF835